These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15469554)
1. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients. Caring for Australians with Renal Impairment (CARI) Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554 [No Abstract] [Full Text] [Related]
2. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient. Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316 [TBL] [Abstract][Full Text] [Related]
3. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence. Hakkert A; Dykeman-Sharpe J CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201 [No Abstract] [Full Text] [Related]
4. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients. Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644 [TBL] [Abstract][Full Text] [Related]
5. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782 [TBL] [Abstract][Full Text] [Related]
7. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
8. DHPG treatment of kidney transplant recipients with severe CMV infection. Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560 [No Abstract] [Full Text] [Related]
9. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989 [TBL] [Abstract][Full Text] [Related]
10. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Rondeau E; Farquet C; Ruedin P; Fries D; Sraer JD Transplant Proc; 1990 Aug; 22(4):1813-4. PubMed ID: 2167536 [No Abstract] [Full Text] [Related]
12. Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient. De Bartolomeis C; Collini A; Barni R; Ruggieri G; Bernini M; Carmellini M Transplant Proc; 2005; 37(6):2504-6. PubMed ID: 16182726 [TBL] [Abstract][Full Text] [Related]
13. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848 [No Abstract] [Full Text] [Related]
14. Gancyclovir prophylaxis in high risk patients. Campino A Transplant Proc; 2005 Dec; 37(10):4311-2. PubMed ID: 16387106 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L; Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546 [TBL] [Abstract][Full Text] [Related]
16. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation. West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740 [TBL] [Abstract][Full Text] [Related]
17. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation. Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763 [TBL] [Abstract][Full Text] [Related]
18. Case Report of a Rare Presentation of Isolated Cytomegalovirus Hepatitis After Renal Transplantation. Soape MP; Rahimi RS; Spak CW; Trotter JF Prog Transplant; 2018 Sep; 28(3):296-298. PubMed ID: 29898621 [No Abstract] [Full Text] [Related]
19. The CARI guidelines. CMV disease and kidney transplant: prophylaxis for cytomegalovirus infection in patients following renal transplantation. Caring for Australians with Renal Impairment (CARI) Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S27-31. PubMed ID: 15469551 [No Abstract] [Full Text] [Related]
20. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. Israni A; Krok K; Cohen D; Blumberg E; Bloom RD Transplant Proc; 2004 Dec; 36(10):3019-24. PubMed ID: 15686685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]